Dear Editor, we would like to share ideas on the publication “Vaccine associated benign
headache and cutaneous hemorrhage after ChAdOx1 nCoV-19 vaccine: A cohort study
1
.” If these symptoms are a minor form of VITT, with a possibility for worsening, such
as in the case of a second vaccination dose, or a new entity of vaccine consequences,
Schultz et al. explored this
1
. The combination of headaches and subcutaneous hemorrhage, according to Schultz et
al., did not indicate VITT, and no other distinct coagulation problem or cerebral
pathology was discovered. In addition to platelet counts and D-dimer, Schultz et al.
noted that symptoms that initially resemble VITT call for caution and a low threshold
for a clinical evaluation
1
.To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Journal of Stroke and Cerebrovascular DiseasesAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Vaccine associated benign headache and cutaneous hemorrhage after ChAdOx1 nCoV-19 vaccine: a cohort study.J Stroke Cerebrovasc Dis. 2022 Nov 17; 32106860
- Dengue after COVID-19 vaccination: possible and might be missed.Clin Appl Thromb Hemost. 2021; 2710760296211047229
Article info
Publication history
Published online: January 23, 2023
Accepted:
December 19,
2022
Received:
November 21,
2022
Publication stage
In Press Corrected ProofFootnotes
We confirm that we have read the Journal's position on issues involved in ethical publication and affirm that this report is consistent with those guidelines
Identification
DOI: https://doi.org/10.1016/j.jstrokecerebrovasdis.2022.106959
Copyright
© 2022 Elsevier Inc. All rights reserved.
ScienceDirect
Access this article on ScienceDirectLinked Article
- Response to Letter to the EditorJournal of Stroke and Cerebrovascular Diseases
- PreviewWe thank the authors for their interest in our article and the thoughtful comments. As they correctly point out, the association between the first vaccination with ChAdOx1 nCov -19 vaccine and the described symptoms in our article does not prove any causality. However, cutaneous hemorrhages and headaches were frequently reported side effects after vaccination with ChAdOx1 nCov-19 in the Norwegian corona study cohort in young and previously healthy subjects. In lack of previous experience, there was a fear that these symptoms may have represented a mild form of VITT.
- Full-Text
- Preview
